Immunology and Microbiology
BCG Vaccine
100%
Nanoemulsion
100%
Infectious Disease
50%
Mycobacterium Tuberculosis
50%
COVID-19
25%
Immunogenicity
25%
Vaccination Schedule
25%
Humoral Immunity
25%
Dendritic Cell
25%
Mycobacteria
25%
Adoptive Immunity
25%
Macrophage
25%
Antigen Identification
25%
Infectious Agent
25%
Genetic Transfection
25%
Cytotoxicity
25%
Immunocompromised Patient
25%
Mycobacterium Bovis BCG
25%
Target Cell
25%
Airborne Bacterium
25%
Pharmacology, Toxicology and Pharmaceutical Science
Vaccine Development
100%
Nanoemulsion
100%
BCG Vaccine
100%
Messenger RNA
100%
mRNA Vaccine
33%
Infection
33%
Mycobacterium Tuberculosis
33%
Infectious Agent
16%
Immunogenicity
16%
Immunocompromised Patient
16%
Mycobacterium Bovis BCG
16%
Pandemic
16%
Airborne Bacterium
16%
Disease
16%
Mycobacteria
16%
Cytotoxicity
16%